| Target Price | HK$9.95 |
| Price | HK$5.75 |
| Potential | |
| Number of Estimates | 4 |
| 4 Analysts have issued a price target Beijing Tong Ren Tang Chines 2027 . The average Beijing Tong Ren Tang Chines target price is HK$9.95. This is higher than the current stock price. The highest price target is , the lowest is . | |
| A rating was issued by 8 analysts: 7 Analysts recommend Beijing Tong Ren Tang Chines to buy, 1 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
| Analyst Estimates: Analysts believe that the Beijing Tong Ren Tang Chines stock has an average upside potential 2027 of . Most analysts recommend the Beijing Tong Ren Tang Chines stock at Purchase. |
| Dec '25 |
2026 Estimates |
|
|---|---|---|
| Revenue Billion HK$ | ??? | ??? |
| ??? | ??? | |
| EBITDA Margin | ??? | ??? |
| ??? | ??? |
4 Analysts have issued a sales forecast Beijing Tong Ren Tang Chines 2026 . The average Beijing Tong Ren Tang Chines sales estimate is
. This is than the revenue of the last 12 months(TTM). The highest sales forecast is , the lowest is .This results in the following potential growth metrics:
| Dec '25 |
2026 Estimates |
|
|---|---|---|
| Earnings Per Share HK$ | ??? | ??? |
| ??? | ??? | |
| P/E | ??? | |
| EV/Sales | ??? |
4 Analysts have issued a Beijing Tong Ren Tang Chines forecast for earnings per share. The average Beijing Tong Ren Tang Chines EPS is
. This is than earnings per share in the financial year 2025. The highest EPS forecast is , the lowest is .This results in the following potential growth metrics and future valuations:
Beijing Tong Ren Tang Chines...
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.


